Nasdaq:US$19.45 (+0.66) | HKEX:HK$30.20 (+0.30) | AIM:£3.05 (+0.08)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF